H. Lundbeck A/S ADR | |
Stock Exchange | Other OTC |
EPS |
$2.82 |
Market Cap |
$8.06 B |
Shares Outstanding |
199.14 M |
Public Float |
- |
H. Lundbeck A/S | |
Stock Exchange | Copenhagen Stock Exchange |
EPS |
DKK18.15 |
Market Cap |
DKK53.61 B |
Shares Outstanding |
199.14 M |
Public Float |
61.22 M |
H. Lundbeck A/S | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
199.1 M |
Public Float |
- |
Address |
Ottiliavej 9 Valby CR 2500 Denmark |
Employees | - |
Website | http://www.lundbeck.com |
Updated | 07/08/2019 |
H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. |